Explore evidence

791 animalsOverall, 791 animals from Ebonyi, Ogun, Ondo, and Oyo States, Nigeria were screened for SARS-CoV-2.

NigeriaCOVID-19published 2023Viruseseurope_pmcdocument of 6 observationsDOI 10.3390/v15051187

8.12 odds_ratioAfter multivariable adjustment, the odds of pre-DM were 8.12 higher in those with a history of COVID-19 compared to controls.

NigeriaCOVID-19 · pre-diabetespublished 2024BMC public healthPubMeddocument of 10 observations

84,414 casesAs of December 2020, approximately 84,414 cases of COVID-19 were identified in Nigeria.

NigeriaCOVID-19observed December 2020HAL · Unilimdocument of 63 observations

1,254 deathsAs of December 2020, 1,254 deaths from COVID-19 were reported in Nigeria.

NigeriaCOVID-19observed December 2020HAL · Unilimdocument of 63 observations

26.2 %Hypertension prevalence was 26.2% among RT-PCR-negative patients and 21.0% among RT-PCR-positive patients.

NigeriaCOVID-19 · hypertension artérielleobserved 27 February 2020 to 30 September 2020published 2021The Nigerian postgraduate medical journalPubMeddocument of 12 observations

1.3 DOT_per_LOTPatients with severe COVID-19 had a mean days of therapy per length of therapy (DOT per LOT) of 1.3.

NigeriaCOVID-19HAL · Unilimdocument of 63 observations

1.2 DOT_per_LOTPatients with mild COVID-19 received antimicrobial therapy with a mean DOT per LOT of 1.2 compared to 1.4 and 1.3 for moderate and severe patients respectively.

NigeriaCOVID-19HAL · Unilimdocument of 63 observations

95.2 %95.2% of participants reported distrust in vaccine safety as a barrier to COVID-19 vaccine uptake.

NigeriaCOVID-19observed April-June 2024published 2026Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument of 8 observations

2.3 %Cancer prevalence was 2.3% among RT-PCR-negative patients and 0.5% among RT-PCR-positive patients.

Nigeriacancer (non précisé) · COVID-19observed 27 February 2020 to 30 September 2020published 2021The Nigerian postgraduate medical journalPubMeddocument of 12 observations

48 facilitiesBetween September 2022 and February 2023, 48 Community Pharmacies, 21 Patent Medicine Stores, and 79 Primary Health Centers were evaluated for COVID-19 antigen rapid diagnostic testing quality in the Federal Capital Territory of Nigeria.

NigeriaCOVID-19observed September 2022 to February 2023published 2024PloS onePubMeddocument of 5 observations

59,287 casesAs of 4th October 2020, Nigeria had 59 287 confirmed cases of COVID-19.

NigeriaCOVID-19observed 4th October 2020published 2021Journal of primary care & community healthPubMeddocument of 3 observations

4.54 aORAge ≥ 50 years was associated with increased odds of severe SARS-CoV-2 disease (adjusted odds ratio 4.54, 95% CI: 1.86–11.08).

NigeriaCOVID-19observed April to July 2020published 2022The Pan African medical journalPubMeddocument of 13 observations

SARS-CoV-2 RNA was detected in almost all animal taxa and sampling locations except Oyo State.

NigeriaCOVID-19published 2023Viruseseurope_pmcdocument of 6 observationsDOI 10.3390/v15051187

271 patientsThe sample size for the study was 271 hospitalized COVID-19 patients.

NigeriaCOVID-19HAL · Unilimdocument of 63 observations

6 patientsSix patients presented with de novo heart failure.

NigeriaCOVID-19 · insuffisance cardiaquepublished 2021Cardiovascular journal of AfricaPubMeddocument of 8 observations

25 %Another study found that spraying resulted in 25.0% surface contamination (n = 12/48) compared to 48.2% (n = 13/27) with wiping.

NigeriaCOVID-19published 2025Journal of public health in Africaeurope_pmcdocument of 3 observations

70 %More than 70% of confirmed COVID-19 cases in Nigeria were concentrated in 7 States: Lagos, Abuja, Oyo, Kano, Edo, Rivers and Delta.

NigeriaCOVID-19published 2020The Pan African medical journalPubMeddocument of 6 observations

0.2 correlation_coefficientThere is a positive relationship between knowledge of COVID-19 and attitude to guidelines (R = 0.20; p < 0.05).

NigeriaCOVID-19published 2022The Pan African medical journalPubMeddocument of 10 observations

67.4 %Fever was noted in 67.4% of patients.

NigeriaCOVID-19published 2022West African journal of medicinePubMeddocument of 15 observations

12,000 casesBy the next three months after 27 February 2020, more than 12,000 cases of COVID-19 were identified in Nigeria.

NigeriaCOVID-19observed three months after 27 February 2020HAL · Unilimdocument of 63 observations

43.5 %Pfizer-BioNTech was the most administered COVID-19 vaccine, accounting for 43.5% of doses.

NigeriaCOVID-19observed April-June 2024published 2026Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument of 8 observations

38 %Among the 45 COVID-19 patients, 38% presented with fever.

NigeriaCOVID-19observed 2020published 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 8 observations

19 monthsThe median time interval between COVID-19 diagnosis and the glycaemic assessment was 19 months.

NigeriaCOVID-19published 2024BMC public healthPubMeddocument of 10 observations

87.8 %Among community health workers in selected States of Nigeria, 87.80% have good knowledge of COVID-19.

NigeriaCOVID-19published 2022The Pan African medical journalPubMeddocument of 10 observations

1.74 aORAttendance of mass gatherings was associated with increased odds of SARS-CoV-2 infection (adjusted odds ratio 1.74, 95% CI: 1.10–2.74).

NigeriaCOVID-19observed April to July 2020published 2022The Pan African medical journalPubMeddocument of 13 observations